Cytodyn Inc (CYDY)

[BlackDoggie]

Sorry, I just realized that I never responded to this. Given that there is still some level of uncertainty - small, but there - I’ve been sticking to the low end of forward P/E multipliers I’ve sampled from the industry. That’s put me using a number around 5x typically. If I was using a probability weighted range, I’d probably end up settling around 8x.

However, as I mentioned previously, that multiplier should go way up if you’re contemplating derisked mono, cancer, and GvHD indications that just haven’t quite crossed the finish line yet. Not saying those are derisked, obviously, just speaking in hypotheticals.